An oral medicine specialist, dermatologist, or your primary care physician can perform an initial assessment
The second observational study looked at the health records of more than 12,000 people and found that GLP-1s were associated with a lower risk of tumour spread in lung, breast, colorectal and liver cancer by just under 40% to 50% (depending on type), compared with older drugs called gliptins
Rare but serious risks include pancreatitis and kidney problems
When a peptide indiscriminately stimulates the release of these two hormones alongside GH, you get a cascade of unwanted effects
Aizawa S, Ookawa K, Kudo T, Asano J, Hayakari M, Tsuchida S
Avoid There is not enough reliable safety information, so it is best avoided unless your doctor advises otherwise